Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$884M |
| 2 |
Tesla
TSLA
|
+$641M |
| 3 |
Visa
V
|
+$520M |
| 4 |
Amazon
AMZN
|
+$457M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$916M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$907M |
| 4 |
Microsoft
MSFT
|
+$832M |
| 5 |
Privia Health
PRVA
|
+$655M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.24% |
| 2 | Financials | 8.33% |
| 3 | Healthcare | 8.04% |
| 4 | Consumer Discretionary | 7.57% |
| 5 | Industrials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Arrowhead Research
ARWR
$11.9B
| $22.9M | ﹤0.01% |
641,086
-71,505
| -10% | -$2.47M |
|
1727
CALL
Occidental Petroleum
OXY
$56.8B
| $22.9M | ﹤0.01% |
388,700
+111,600
| +40% | +$6.7M |
|
1728
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
| $22.8M | ﹤0.01% |
290,797
-3,935
| -1% | -$307K |
|
1729
iShares Gold Trust
IAU
$62.9B
| $22.8M | ﹤0.01% |
626,086
+23,409
| +4% | +$878K |
|
1730
Piper Sandler
PIPR
$5.12B
| $22.8M | ﹤0.01% |
704,632
-19,852
| -3% | -$656K |
|
|
EQC
1731
DELISTED
Equity Commonwealth
EQC
| $22.8M | ﹤0.01% |
1,123,735
-269,208
| -19% | -$5.57M |
|
1732
Copa Holdings
CPA
$5.76B
| $22.7M | ﹤0.01% |
205,648
+43,493
| +27% | +$4.36M |
|
1733
Ziff Davis
ZD
$1.96B
| $22.7M | ﹤0.01% |
324,057
+106,244
| +49% | +$7.27M |
|
1734
Agios Pharmaceuticals
AGIO
$1.79B
| $22.6M | ﹤0.01% |
799,612
-164,550
| -17% | -$4.09M |
|
1735
Guardant Health
GH
$21.7B
| $22.6M | ﹤0.01% |
631,764
-301,066
| -32% | -$8.65M |
|
1736
Dyne Therapeutics
DYN
$4.7B
| $22.6M | ﹤0.01% |
2,009,529
+515,079
| +34% | +$6.08M |
|
1737
PUT
Altria Group
MO
$114B
| $22.6M | ﹤0.01% |
498,600
| – | – |
|
1738
Green Plains
GPRE
$1.18B
| $22.5M | ﹤0.01% |
698,828
-71,214
| -9% | -$2.26M |
|
|
STR
1739
DELISTED
Sitio Royalties
STR
| $22.5M | ﹤0.01% |
857,160
-129,375
| -13% | -$3.31M |
|
1740
Evolent Health
EVH
$348M
| $22.5M | ﹤0.01% |
742,830
-236,109
| -24% | -$7.63M |
|
1741
Chesapeake Utilities
CPK
$3.19B
| $22.5M | ﹤0.01% |
189,090
-19,364
| -9% | -$2.45M |
|
1742
Insight Enterprises
NSIT
$3.89B
| $22.5M | ﹤0.01% |
153,652
+22,998
| +18% | +$3.09M |
|
1743
BioNTech
BNTX
$22.9B
| $22.4M | ﹤0.01% |
207,731
-98,092
| -32% | -$11M |
|
1744
Brookfield Infrastructure Partners
BIP
$19.2B
| $22.4M | ﹤0.01% |
613,801
-111,315
| -15% | -$3.97M |
|
1745
iShares MSCI EAFE Value ETF
EFV
$28.8B
| $22.4M | ﹤0.01% |
457,112
+16,218
| +4% | +$798K |
|
1746
Standex International
SXI
$3.59B
| $22.3M | ﹤0.01% |
157,767
-97,547
| -38% | -$12.9M |
|
1747
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $22.3M | ﹤0.01% |
230,755
-1,282,218
| -85% | -$126M |
|
1748
Knight Transportation
KNX
$11.3B
| $22.3M | ﹤0.01% |
401,183
-1,170,627
| -74% | -$65.3M |
|
1749
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.04B
| $22.3M | ﹤0.01% |
385,192
+1,290
| +0.3% | +$71.1K |
|
1750
Vaxcyte
PCVX
$7.81B
| $22.3M | ﹤0.01% |
445,845
-52,506
| -11% | -$2.49M |
|
Similar funds
Goldman Sachs's Q2 2023 Portfolio in Review
As of Q2 2023, Goldman Sachs held 6,313 positions worth $466B, up 7.1% from $435B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q2 2023 filing shows 443 new, 2,419 increased, 2,272 reduced and 593 closed positions. Its largest new stake was Pelagos Insurance Capital: 15,246,144 shares worth $208M. The largest sale was Invesco QQQ Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q2 2023 buy was Pelagos Insurance Capital: 15,246,144 shares worth $208M.
- Goldman Sachs added most to Alphabet (Google) Class A in Q2 2023, an estimated $884M increase.
- Goldman Sachs's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.14B.
- Goldman Sachs fully exited DCP Midstream, LP in Q2 2023, selling an estimated $250M.
- Goldman Sachs's ten largest holdings make up 19% of its $466B portfolio in Q2 2023.
- Goldman Sachs opened 443 new positions and closed 593 in Q2 2023.
- Goldman Sachs's portfolio value rose 7.1% quarter-over-quarter to $466B.
Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.